$CALM

Cal-Maine Foods Stock Falls 3% After Slipping To Loss In Q1

Cal-Maine Foods (CALM) fell 3% to $66.49 after reporting a Q1 loss of $58.62M, or $1.26 per share, compared to a profit last year. Net sales dropped 41.5% to $539.61M. The stock traded between $63.50 and $95.57 over the past year.

Original reporting
Published Sep 30, 2026, 4:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 6:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine Foods Stock Falls 3% After Slipping To Loss In Q1 — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

The surprise loss and 41% sales decline suggest weaker demand and possible pricing pressure, likely weighing on the stock and sector.

02

Market read

Earnings miss drives immediate price decline and may affect consumer‑staples sentiment.

03

What to watch

Potential cost‑saving measures or pricing power in a tight supply environment may mitigate long‑term impact.

Relevance 7/10Novelty 7/10Timing: today

Background

Cal-Maine Foods is the largest U.S. egg producer; its earnings are closely watched for consumer‑staple trends.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine Foods reported a Q1 net loss of $58.6M, causing the stock to fall 3% intraday.

Expected impact

downward pressure as the market prices in the unexpected loss

Evidence & confidence

Losses are sizable relative to prior profit and sales fell 41.5%; investors typically react negatively to such earnings surprises.

Market effects

Egg producers may see broader pressure as demand concerns surface.

U.S. consumer staples index could see a modest dip.

Limited to U.S. market; no global ripple expected.

Counterpoint

If the loss reflects a temporary demand shock, the stock could rebound on a short‑cover rally.

Key entities

  • Cal-Maine Foods, Inc.

    U.S. egg producer reporting Q1 loss.

Related articles

$LQDAMed

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Rogers rose 10% on higher earnings guidance ($3.80 vs. $3.65 consensus). Liquidia fell 25% after a patent infringement ruling, while United Therapeutics gained 15%. Jabil dropped 7% despite beating earnings and revenue estimates. Concentrix climbed 5% on strong earnings but issued weak guidance. Moderna fell 7% after a Citi downgrade. FormFactor gained 8% on a Deutsche Bank buy rating. Cal-Maine Foods declined 2% on a wider-than-expected loss.

$CALMMedAI 8/10

Maine Foods Q1 fiscal 2027 earnings loss

Cal-Maine Foods reported a Q1 2027 net loss of $58.6M, down from a $199.3M profit a year earlier, due to lower egg prices and sales. Net sales fell 41.5% to $539.6M. CEO Sherman Miller cited industry overproduction. Shares dropped 3.4% to $66.22. The company settled a price-rigging allegation earlier this year.

$CALMHighAI 8/10

Cal-Maine (CALM) Stock Trades Down, Here Is Why

Cal-Maine Foods (CALM) reported a Q3 2026 net loss, with net sales down 41.5% YoY to $539.6M, missing estimates. Gross profit fell to $403K, and the company posted a net loss of $58.6M. CEO Sherman Miller attributed results to industry supply imbalance. Shares fell 3%, trading at $66.49.

$CALMMedAI 8/10

Cal-Maine Foods Q1 2027 Earnings Call: Complete Transcript - Cal-Maine Foods (NASDAQ:CALM)

Cal-Maine Foods (NASDAQ:CALM) reported Q1 FY2027 net sales down 41.5% to $539.6M and a net loss of $58.6M. The company faces pressure from an oversupplied egg market but is expanding specialty eggs and prepared foods. It plans a 60% increase in prepared foods capacity by H1 FY2028 and has $767.6M in cash. Management repurchased $14.9M in shares post-quarter, focusing on long-term growth.